Age
Item
men or women 18 years of age or older
boolean
C0001779 (UMLS CUI [1])
Multiple Myeloma Staging system | Diphosphonates Intravenous | pamidronate | zoledronic acid
Item
confirmed diagnosis of multiple myeloma(mm) by durie and dalmon staging criteria on iv bisphosphonate therapy with either pamidronate or zoledronic acid for 8-12 months
boolean
C0026764 (UMLS CUI [1,1])
C0449394 (UMLS CUI [1,2])
C0012544 (UMLS CUI [2,1])
C1522726 (UMLS CUI [2,2])
C0043603 (UMLS CUI [3])
C0257685 (UMLS CUI [4])
Multiple Myeloma In complete remission | Multiple Myeloma partial response
Item
mm patients in either cr or pr by ebmt criteria
boolean
C0026764 (UMLS CUI [1,1])
C0677874 (UMLS CUI [1,2])
C0026764 (UMLS CUI [2,1])
C1521726 (UMLS CUI [2,2])
ECOG performance status
Item
ecog performance status of 0-2
boolean
C1520224 (UMLS CUI [1])
Therapeutic procedure Multiple Myeloma | Maintenance treatment allowed
Item
mm patients on active anti-mm therapy (maintenance regimens allowed)
boolean
C0087111 (UMLS CUI [1,1])
C0026764 (UMLS CUI [1,2])
C0814469 (UMLS CUI [2,1])
C0683607 (UMLS CUI [2,2])
Kidney Failure | Creatinine measurement, serum | Creatinine clearance measurement
Item
renal failure with serum creatinine >2mg/dl and/or creatinine clearance of <30ml/min
boolean
C0035078 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0373595 (UMLS CUI [3])
Recurrent disease | Refractory Disease | Progressive Disease
Item
relapsed, refractory or progressive disease
boolean
C0277556 (UMLS CUI [1])
C1514815 (UMLS CUI [2])
C1335499 (UMLS CUI [3])
Condition At risk Patient | Situation At risk Patient | Condition Interferes with Research results | Situation Interferes with Research results | Condition Interferes with Study Subject Participation Status | Situation Interferes with Study Subject Participation Status
Item
any condition or situation that, in the opinion of the investigator, may put the subject at significant risk, confound the results of the study, or interfere significantly with the subject's participation in the study
boolean
C0348080 (UMLS CUI [1,1])
C1444641 (UMLS CUI [1,2])
C0030705 (UMLS CUI [1,3])
C0748872 (UMLS CUI [2,1])
C1444641 (UMLS CUI [2,2])
C0030705 (UMLS CUI [2,3])
C0348080 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C0683954 (UMLS CUI [3,3])
C0748872 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C0683954 (UMLS CUI [4,3])
C0348080 (UMLS CUI [5,1])
C0521102 (UMLS CUI [5,2])
C2348568 (UMLS CUI [5,3])
C0748872 (UMLS CUI [6,1])
C0521102 (UMLS CUI [6,2])
C2348568 (UMLS CUI [6,3])
Hypersensitivity Zoledronic acid Dose Single | Medical contraindication Zoledronic acid Dose Single
Item
hypersensitivity or any contraindication to a single dose of zoledronic acid
boolean
C0020517 (UMLS CUI [1,1])
C0257685 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0205171 (UMLS CUI [1,4])
C1301624 (UMLS CUI [2,1])
C0257685 (UMLS CUI [2,2])
C0178602 (UMLS CUI [2,3])
C0205171 (UMLS CUI [2,4])